China NMPA Product Recall - Electronic endotracheal intubation endoscope

Olympus Medical Systems Co., Ltd., via its subsidiary Olympus Trading (Shanghai) Co., Ltd., initiated a voluntary Class III recall of its electronic endoscopic tubes, reported to China's National Medical Products Administration (NMPA) on April 23, 2023. The recall stems from significant inconsistencies found between the reprocessing parameters detailed in the company's 510(K) supplemental information and the corresponding label information on previously sold units. This discrepancy affects products covered under National Medical Device Registration Certificate No. 20183062428. While no specific inspection dates were provided, this proactive measure addresses a critical regulatory non-conformity concerning product labeling and instructions vital for patient safety and device efficacy. As a Class III recall, the NMPA indicates that the identified issue is unlikely to cause adverse health consequences. Olympus's required action involves recalling the affected electronic endoscopic tubes, with detailed information on specific models, specifications, and batch numbers available in the supplementary Medical Device Recall Table and Event Report Form. This action underscores the company's commitment to correcting documentation discrepancies and adhering to NMPA regulatory standards.